drugset / Trial / NCT01657201

Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

NCT01657201

Phase 1 Completed 59 enrolled Samyang Biopharmaceuticals Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the pharmacokinetic properties and safety of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend).

Timeline

Start
2012-09
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject SYP-1018 Unknown 200 mg Intravenous
Subject Voriconazole Small molecule 200 mg Intravenous

Indications